Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on May 10, 2013. The report announces the financial results for the first quarter ended March 31, 2013. The detailed financial data is contained in a press release attached as Exhibit 99.01, which is incorporated by reference but not deemed "filed" under Section 18 of the Exchange Act.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.01), which is not included in the input text.
Material Changes
The filing does not provide specific data to compare current period results against prior comparable periods. It serves solely as a notification that the Q1 2013 results have been issued.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These elements are presumed to be within the referenced press release.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) in the attached Exhibit 99.01 press release.
- Confirm the company name is Neuralstem, Inc., as the input metadata incorrectly listed Palisade Bio, Inc.
- Review the full press release for any forward-looking statements or guidance not captured in this summary.
- Note that the financial information in this 8-K is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.